CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
89.35
-0.44 (-0.49%)
At close: Nov 13, 2026, 4:00 PM EST
90.24
+0.89 (1.00%)
Pre-market: Nov 16, 2026, 8:34 AM EST

CVS Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
114,321100,74256,490101,613122,449136,274
Market Cap Growth
12.21%78.34%-44.41%-17.02%-10.15%52.43%
Enterprise Value
174,731171,444129,676165,694173,860202,401
Last Close Price
89.3577.0041.7770.5280.6287.28

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
10.4156.9812.2412.1828.4017.03
Forward PE
10.5511.547.779.3910.6712.88
PS Ratio
0.270.250.150.280.380.47
PB Ratio
1.421.340.751.331.711.81
P/FCF Ratio
7.3412.908.939.789.108.65
P/OCF Ratio
6.119.476.207.577.577.46
PEG Ratio
0.820.760.611.922.052.15

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
0.420.430.350.470.540.70
EV/EBITDA Ratio
10.1011.7210.288.998.7110.86
EV/EBIT Ratio
13.6817.1116.1711.7711.0414.30
EV/FCF Ratio
11.2221.9620.5015.9412.9312.86

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.931.061.101.040.991.01
Debt / EBITDA Ratio
3.714.535.303.683.063.48
Debt / FCF Ratio
4.8410.2413.117.645.264.83
Net Debt / Equity Ratio
0.750.920.950.890.770.84
Net Debt / EBITDA Ratio
3.494.745.703.682.763.41
Net Debt / FCF Ratio
3.888.8811.376.544.094.03
Asset Turnover
1.631.581.471.491.401.25
Inventory Turnover
19.4018.5617.7916.3514.5413.24
Quick Ratio
0.610.570.560.590.620.55
Current Ratio
0.850.840.810.860.950.89
Return on Equity (ROE)
14.36%2.29%6.02%11.28%5.88%11.01%
Return on Assets (ROA)
3.11%2.47%1.99%3.68%4.27%3.82%
Return on Invested Capital (ROIC)
8.22%5.54%4.09%7.77%8.79%7.59%
Return on Capital Employed (ROCE)
7.70%6.10%4.80%8.30%9.90%8.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
9.60%1.75%8.17%8.21%3.52%5.87%
FCF Yield
13.62%7.75%11.20%10.23%10.98%11.55%
Dividend Yield
2.98%3.36%5.93%3.07%2.34%1.94%
Payout Ratio
31.00%192.14%73.10%37.54%67.43%32.81%
Buyback Yield / Dilution
-1.66%-0.71%2.17%2.49%0.45%-1.14%
Total Shareholder Return
1.32%2.64%8.10%5.56%2.79%0.80%
SEC Filings: 10-K · 10-Q